In Vitro and In Vivo antimicrobial activities of gallium nitrate against multidrug-resistant acinetobacter baumannii

Antimicrobial Agents and Chemotherapy

Volumn 56, Issue 11, 2012, Pages 5961-5970

  Antunes, Luísa C S ^a   Imperi, Francesco ^b   Minandri, Fabrizia ^a   Visca, Paolo ^a  

^a ROMA TRE UNIVERSITY   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

COLISTIN; FERRIC UPTAKE REGULATOR; GALLIUM NITRATE; IRON; OXIDOREDUCTASE;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTION; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIUM ISOLATE; BLOODSTREAM INFECTION; CHEMOTHERAPY; CONTROLLED STUDY; CULTURE MEDIUM; GALLERIA MELLONELLA; GENE EXPRESSION; GROWTH INHIBITION; HUMAN; IRON METABOLISM; LARVA; NONHUMAN; PRIORITY JOURNAL; SURVIVAL RATE;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; COLISTIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE, MULTIPLE, BACTERIAL; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; GALLIUM; HUMANS; INHIBITORY CONCENTRATION 50; IRON; LARVA; MOTHS; REPRESSOR PROTEINS;

EID: 84868012115     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01519-12     Document Type: Article

References (65)

1. Aisen P, Leibman A, Zweier J. 1978. Stoichiometric and site characteristics of the binding of iron to human transferrin. J. Biol. Chem. 253: 1930-1937.
2. Antunes LC, Imperi F, Carattoli A, Visca P. 2011. Deciphering the multifactorial nature of Acinetobacter baumanniipathogenicity. PLoS One 6:e22674. doi:10.1371/journal.pone.0022674.
3. Antunes LC, Imperi F, Towner KJ, Visca P. 2011. Genome-assisted identification of putative iron-utilization genes in Acinetobacter baumannii and their distribution among a genotypically diverse collection of clinical isolates. Res. Microbiol. 162:279-284.
4. Aperis G, et al. 2007. Galleria mellonella as a model host to study infection by the Francisella tularensis live vaccine strain. Microbes Infect. 9:729 - 734.
5. Baldoni D, Steinhuber A, Zimmerli W, Trampuz A. 2010. in vitro activity of gallium maltolate against Staphylococci in logarithmic, stationary, and biofilm growth phases: comparison of conventional and calori-metric susceptibility testing methods. Antimicrob. Agents Chemother. 54:157-163.
6. Banin E, et al. 2008. The potential of desferrioxamine-gallium as an anti-Pseudomonas therapeutic agent. Proc. Natl. Acad. Sci. U. S. A. 105: 16761-16766.
7. Bergogne-Bérézin E, Towner KJ. 1996. Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features. Clin. Microbiol. Rev. 9:148-165.
8. Bernstein LR. 1998. Mechanisms of therapeutic activity for gallium. Pharmacol. Rev. 50:665-682.
9. Braud A, Hannauer M, Mislin GL, Schalk IJ. 2009. The Pseudomonas aeruginosapyochelin-iron uptake pathway and its metal specificity. J. Bacteriol. 191:3517-3525.
10. Braud A, Hoegy F, Jezequel K, Lebeau T, Schalk IJ. 2009. New insights into the metal specificity of the Pseudomonas aeruginosa pyoverdine-iron uptake pathway. Environ. Microbiol. 11:1079-1091.
11. Braun V, Hantke K. 2011. Recent insights into iron import by bacteria. Curr. Opin. Chem. Biol. 15:328-334.
12. Capone A, D'Arezzo S, Visca P, Petrosillo N; GRAB. 2008. in vitro activity of tigecycline against multidrug-resistant Acinetobacter baumannii. J. Antimicrob. Chemother. 62:422-423.
13. Coleman M, et al. 2010. in vitro antimicrobial activity of gallium maltolate against virulent Rhodococcus equi. Vet. Microbiol. 146:175-178.
14. Collery P, Keppler B, Madoulet C, Desoize B. 2002. Gallium in cancer treatment. Crit. Rev. Oncol. Hematol. 42:283-296.
15. D'Andrea MM, et al. 2009. Characterization of pABVA01, a plasmid encoding the OXA-24 carbapenemase from Italian isolates of Acinetobacter baumannii. Antimicrob. Agents Chemother. 53:3528-3533.
16. D'Arezzo S, et al. 2009. Epidemic multidrug-resistant Acinetobacter baumannii related to European clonal types I and II in Rome (Italy). Clin. Microbiol. Infect. 15:347-357.
17. DeLeon K, et al. 2009. Gallium maltolate treatment eradicates Pseudomonas aeruginosa infection in thermally injured mice. Antimicrob. Agents Chemother. 53:1331-1337.
18. de Léséleuc L, Harris G, Kuolee R, Chen W. 23 July 2012. in vitro and in vivo biological activity of iron chelators and gallium nitrate against Acinetobacter baumannii. Antimicrob. Agents Chemother. doi: 10.1128/AAC.00778-12.
19. Dijkshoorn L, Nemec A, Seifert H. 2007. An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii. Nat. Rev. Microbiol. 5:939-951.
20. DuBois D, DuBois EF. 1916. Clinical calorimetry: formula to estimate approximate surface area if height and weight be known. Arch. Int. Med. 17:863-871.
21. Dunphy GB, Niven DF, Chadwick JS. 2002. Iron contributes to the antibacterial functions of the haemolymph of Galleria mellonella. J. Insect Physiol. 48:903-914.
22. Emery T. 1986. Exchange of iron by gallium in siderophores. Biochemistry 25:4629-4633.
23. Fecteau ME, et al. 2011. Antimicrobial activity of gallium nitrate against Mycobacterium avium subsp. paratuberculosis in neonatal calves. J. Vet. Intern. Med. 25:1152-1155.
24. Funahashi T, et al. 2012. Identification and characterization of an outer membrane receptor gene in Acinetobacter baumannii required for utilization of desferricoprogen, rhodotorulic acid, and desferrioxamine B as xe-nosiderophores. Biol. Pharm. Bull. 35:753-760.
25. T with human lung epithelial cells, Galleria mellonella caterpillars, and mice. Infect. Immun. 80:1015-1024.
26. Gales AC, Reis AO, Jones RN. 2001. Contemporary assessment of antimicrobial susceptibility testing methods for polymyxin B and colistin: review of available interpretative criteria and quality control guidelines. J. Clin. Microbiol. 39:183-190.
27. Higgins PG, Stefanik D, Page MG, Hackel M, Seifert H. 2012. in vitro activity of the siderophore monosulfactam BAL30072 against mero-penem-non- susceptible Acinetobacter baumannii. J. Antimicrob. Chemother. 67:1167-1169.
28. Iacono M, et al. 2008. Whole-genome pyrosequencing of an epidemic multidrug-resistant Acinetobacter baumannii strain belonging to the European clone II group. Antimicrob. Agents Chemother. 52:2616-2625.
29. Imperi F, et al. 2011. The genomics of Acinetobacter baumannii: insights into genome plasticity, antimicrobial resistance and pathogenicity. IUBMB Life 63:1068-1074.
30. Jacobs AC, et al. 2012. Characterization of the Acinetobacter baumannii growth phase-dependent and serum responsive transcriptomes. FEMS Immunol. Med. Microbiol. 64:403-412.
31. Kaneko Y, Thoendel M, Olakanmi O, Britigan BE, Singh PK. 2007. The transition metal gallium disrupts Pseudomonas aeruginosa iron metabolism and has antimicrobial and antibiofilm activity. J. Clin. Invest. 117: 877-888.
32. Kempf M, Rolain JM. 2012. Emergence of resistance to carbapenems in Acinetobacter baumannii in Europe: clinical impact and therapeutic options. Int. J. Antimicrob. Agents 39:105-114.
33. Lee JW, Helmann JD. 2007. Functional specialization within the Fur family of metalloregulators. Biometals 20:485-499.
34. Li J, et al. 2006. Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections. Lancet Infect. Dis. 6:589-601.
35. MacKenzie FM, et al. 2005. Report of the Consensus Conference on Antibiotic Resistance; Prevention and Control (ARPAC). Clin. Microbiol. Infect. 11:938-954.
36. Michalopoulos A, Falagas ME. 2010. Treatment of Acinetobacter infections. Expert Opin. Pharmacother. 11:779-788.
37. Miller JH. 1972. Experiments in molecular genetics, p 252-255. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
38. Nemec A, Dijkshoorn L, van der Reijden TJ. 2004. Long-term predominance of two pan-European clones among multi-resistant Acinetobacter baumannii strains in the Czech Republic. J. Med. Microbiol. 53:147-153.
39. Nerren JR, et al. 2011. Evaluation of the effect of gallium maltolate on fecal Salmonella shedding in cattle. J. Food Prot. 74:524-530.
40. Olakanmi O, Britigan BE, Schlesinger LS. 2000. Gallium disrupts iron metabolism of mycobacteria residing within human macrophages. Infect. Immun. 68:5619-5627.
41. Olakanmi O, et al. 2010. Gallium disrupts iron uptake by intracellular and extracellular Francisella strains and exhibits therapeutic efficacy in a murine pulmonary infection model. Antimicrob. Agents Chemother. 54: 244-253.
42. Payne SM. 1994. Detection, isolation, and characterization of sidero-phores. Methods Enzymol. 235:329-344.
43. Peeters E, Nelis HJ, Coenye T. 2008. Resistance of planktonic and bio-film-grown Burkholderia cepacia complex isolates to the transition metal gallium. J. Antimicrob. Chemother. 61:1062-1065.
44. Peleg AY, et al. 2009. Galleria mellonella as a model system to study Acinetobacter baumannii pathogenesis and therapeutics. Antimicrob. Agents Chemother. 53:2605-2609.
45. Perez F, et al. 2007. Global challenge of multidrug-resistant Acinetobacter baumannii. Antimicrob. Agents Chemother. 51:3471-3484.
46. Petersen PJ, Labthavikul P, Jones CH, Bradford PA. 2006. in vitro antibacterial activities of tigecycline incombination with other antimicrobial agents determined by chequerboard and time-kill kinetic analysis. J. Antimicrob. Chemother. 57:573-576.
47. Raetz CR, Reynolds CM, Trent MS, Bishop RE. 2007. Lipid A modification systems in Gram-negative bacteria. Annu. Rev. Biochem. 76:295-329.
48. Reagan-Shaw S, Nihal M, Ahmad N. 2008. Dose translation from animal to human studies revisited. FASEB J. 22:659-661.
49. Roca I, Espinal P, Vila-Farrés X, Vila J. 2012. The Acinetobacter bau-mannii oxymoron: commensal hospital dweller turned pan-drug-resistant menace. Front. Microbiol. 3:148.
50. 3+ is influenced by ligand complexation as well as the bacterial carbon source. Antimicrob. Agents Chemother. 55:5568-5580.
51. Sambrook J, Fitsch EF, Maniatis T. 1989. Molecular cloning: a laboratory manual, p 2344. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
52. Schwyn B, Neilands JB. 1987. Universal chemical assay for the detection and determination of siderophores. Anal. Biochem. 160:47-56.
53. Smith MG, et al. 2007. New insights into Acinetobacter baumannii pathogenesis revealed by high-density pyrosequencing and transposon mutagenesis. Genes Dev. 21:601-614.
54. Spaink HP, Okker RJH, Wijffelman CA, Pees E, Lugtenberg BJJ. 1987. Promoters in the nodulation region of the Rhizobium leguminosarum Sym plasmid pRL1J1. Plant Mol. Biol. 9:27-39.
55. Stojiljkovic I, Baumler AJ, Hantke K. 1994. Fur regulon in Gram negative bacteria. Identification and characterization of new iron-regulated Escherichia coli genes by a Fur titration assay. J. Mol. Biol. 236:531-544.
56. Thompson MG, Corey BW, Si Y, Craft DW, Zurawski DV. 30 July 2012. Antibacterial activities of iron chelators against common nosocomial pathogens. Antimicrob. Agents Chemother. doi:10.1128/AAC.01197-12.
57. Towner KJ, et al. 2011. Distribution of intrinsic plasmid replicase genes and their association with carbapenem-hydrolyzing class D beta-lactamase genes in European clinical isolates of Acinetobacter baumannii. Antimicrob. Agents Chemother. 55:2154-2159.
58. Vallenet D, et al. 2008. Comparative analysis of Acinetobacters: three genomes for three lifestyles. PLoS One 3:e1805. doi:10.1371/ journal.pone.0001805.
59. van Dessel H, et al. 2004. Identification of a new geographically widespread multiresistant Acinetobacter baumannii clone from European hospitals. Res. Microbiol. 2:105-112.
60. Visca P, Ciervo A, Sanfilippo V, Orsi N. 1993. Iron-regulated salicylate synthesis by Pseudomonas spp. J. Gen. Microbiol. 139:1995-2001.
61. Visca P, Seifert H, Towner KJ. 2011. Acinetobacter infection - an emerging threat to human health. IUBMB Life 63:1048-1054.
62. Warrell RP, Jr, Skelos A, Alcock NW, Bockman RS. 1986. Gallium nitrate for acute treatment of cancer-related hypercalcemia: clinicophar-macological and dose response analysis. Cancer Res. 46:4208-4212.
63. + interaction with FbpA. J. Biol. Inorg. Chem. 13:887-898.
64. Weinberg ED. 2009. Iron availability and infection. Biochim. Biophys. Acta 1790:600 - 605.
65. Yamamoto S, Okujo N, Kataoka H, Narimatsu S. 1999. Siderophore-mediated utilization of transferrin- and lactoferrin-bound iron by Acinetobacter baumannii. J. Health Sci. 45:297-302.